Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
OLGA EMERY, V.
GILLIE, EDWARD X.
and
SMITH, JOSEPH A.
2000.
Interface between Vascular Dementia and Alzheimer Syndrome: Nosologic Redefinition.
Annals of the New York Academy of Sciences,
Vol. 903,
Issue. 1,
p.
229.
Reisberg, Barry
Doody, Rachelle
Stöffler, Albrecht
Schmitt, Frederick
Ferris, Steven
and
Möbius, Hans Jörg
2003.
Memantine in Moderate-to-Severe Alzheimer's Disease.
New England Journal of Medicine,
Vol. 348,
Issue. 14,
p.
1333.
Emery, V. Olga
Gillie, Edward X.
and
Smith, Joseph A.
2005.
Noninfarct vascular dementia and Alzheimer dementia spectrum.
Journal of the Neurological Sciences,
Vol. 229-230,
Issue. ,
p.
27.
Ebmeier, K.P.
Donaghey, C.
and
Dougall, N.J.
2005.
Neuroimaging, Part B.
Vol. 67,
Issue. ,
p.
43.
Reisberg, Barry
2006.
Diagnostic Criteria in Dementia: A Comparison of Current Criteria, Research Challenges, and Implications for DSM-V.
Journal of Geriatric Psychiatry and Neurology,
Vol. 19,
Issue. 3,
p.
137.
Desideri, Giovambattista
Cipollone, Francesco
Necozione, Stefano
Marini, Carmine
Lechiara, Maria Carmela
Taglieri, Guglielmo
Zuliani, Giovanni
Fellin, Renato
Mezzetti, Andrea
di Orio, Ferdinando
and
Ferri, Claudio
2008.
Enhanced soluble CD40 ligand and Alzheimer's disease: Evidence of a possible pathogenetic role.
Neurobiology of Aging,
Vol. 29,
Issue. 3,
p.
348.
Revell, Andrew J.
Caskie, Grace I. L.
Willis, Sherry L.
and
Schaie, K. Warner
2009.
Factor Structure and Invariance of the Quality of Life in Alzheimer's Disease (QoL-AD) Scale.
Experimental Aging Research,
Vol. 35,
Issue. 2,
p.
250.
Farlow, Martin R.
Salloway, Stephen
Tariot, Pierre N.
Yardley, Jane
Moline, Margaret L.
Wang, Qin
Brand-Schieber, Elimor
Zou, Heng
Hsu, Timothy
and
Satlin, Andrew
2010.
Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study.
Clinical Therapeutics,
Vol. 32,
Issue. 7,
p.
1234.
McArthur, C.
Jampana, R.
Patterson, J.
and
Hadley, D.
2011.
Applications of cerebral SPECT.
Clinical Radiology,
Vol. 66,
Issue. 7,
p.
651.
Tariot, Pierre
Salloway, Steven
Yardley, Jane
Mackell, Joan
and
Moline, Margaret
2012.
Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease.
BMC Research Notes,
Vol. 5,
Issue. 1,
Robinson, Petra
Giorgi, Barbro
and
Ekman, Sirkka-Liisa
2012.
The Lived Experience of Early-Stage Alzheimer’s Disease: A Three-Year Longitudinal Phenomenological Case Study.
Journal of Phenomenological Psychology,
Vol. 43,
Issue. 2,
p.
216.
Brice, Alejandro E.
Wallace, Sarah E.
and
Brice, Roanne G.
2014.
Alzheimer’s Dementia From a Bilingual/Bicultural Perspective.
Communication Disorders Quarterly,
Vol. 36,
Issue. 1,
p.
55.
Parimisetty, Avinash
Dorsemans, Anne-Claire
Awada, Rana
Ravanan, Palaniyandi
Diotel, Nicolas
and
Lefebvre d’Hellencourt, Christian
2016.
Secret talk between adipose tissue and central nervous system via secreted factors—an emerging frontier in the neurodegenerative research.
Journal of Neuroinflammation,
Vol. 13,
Issue. 1,
Hong, Yun Jeong
Choi, Seong Hye
Jeong, Jee Hyang
Park, Kyung Won
Na, Hae Ri
and
Seo, Sang-Won
2018.
Effectiveness of Anti-Dementia Drugs in Extremely Severe Alzheimer’s Disease: A 12-Week, Multicenter, Randomized, Single-Blind Study.
Journal of Alzheimer's Disease,
Vol. 63,
Issue. 3,
p.
1035.
Minn, Yang-Ki
Choi, Seong Hye
Suh, Young Ju
Jeong, Jee Hyang
Kim, Eun-Joo
Kim, Jong Hun
Park, Kyung Won
Park, Moon Ho
Youn, Young Chul
Yoon, Bora
Choi, Seok-Jin
Oh, Youn Kyung
Yoon, Soo Jin
and
Seo, Sang Won
2018.
Effect of Physical Activity on the Progression of Alzheimer’s Disease: The Clinical Research Center for Dementia of South Korea Study.
Journal of Alzheimer's Disease,
Vol. 66,
Issue. 1,
p.
249.
Kim, Young Hyo
Lee, Sang-Myung
Cho, Sungbo
Kang, Ju-Hee
Minn, Yang-Ki
Park, Hyelim
and
Choi, Seong Hye
2019.
Amyloid beta in nasal secretions may be a potential biomarker of Alzheimer’s disease.
Scientific Reports,
Vol. 9,
Issue. 1,
Park, Hee Kyung
Jeong, Jee Hyang
Moon, So Young
Park, Yoo Kyoung
Hong, Chang Hyung
Na, Hae Ri
Song, Hong-Sun
Lee, Sun Min
Choi, Muncheong
Park, Kyung Won
Kim, Byeong C.
Cho, Soo Hyun
Chun, Buong-O
and
Choi, Seong Hye
2020.
South Korean Study to Prevent Cognitive Impairment and Protect Brain Health Through Lifestyle Intervention in At-Risk Elderly People: Protocol of a Multicenter, Randomized Controlled Feasibility Trial.
Journal of Clinical Neurology,
Vol. 16,
Issue. 2,
p.
292.
Luo, Jiefeng
Chen, Liechun
Huang, Xiaohua
Xie, Jieqiong
Zou, Chun
Pan, Mika
Mo, Jingjia
and
Zou, Donghua
2022.
REPS1 as a Potential Biomarker in Alzheimer’s Disease and Vascular Dementia.
Frontiers in Aging Neuroscience,
Vol. 14,
Issue. ,